[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337336-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-337336-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","progressive-plasticity-during-colorectal-cancer-metastasis-research-findings","Progressive plasticity during colorectal cancer metastasis - Research findings","","Cancer progression makes metastatic tumors more aggressive and less responsive, while accumulated mutations often remain similar between primary and metastatic sites. This mismatch suggests a major contribution from non-genetic phenotypic plasticity, yet metastatic cell-state transitions remain unclear. Using patient-matched biospecimen trios and matched patient-derived organoids, the study shows metastases undergo progressive plasticity: a conserved fetal progenitor state followed by non-canonical squamous and neuroendocrine-like differentiation. The process is intensified in metastasis and chemotherapy and linked to poor survival, with PROX1 acting as a repressor.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/progressive-plasticity-during-colorectal-cancer-metastasis-research-findings/337336/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/progressive-plasticity-during-colorectal-cancer-metastasis-research-findings/337336.png","ImageObject",300,407,{"name":42,"@type":43},"Aurelia","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What does the study propose about metastatic progression in colorectal cancer?","Question",{"text":63,"@type":64},"Metastatic tumors progress through an ordered, progressive plasticity program rather than relying mainly on genetic differences, enabling major phenotypic state transitions.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What distinct cell-state transitions are reported from primary tumors to metastases?",{"text":68,"@type":64},"The progression follows three ordered steps: enriched LGR5+ ISC-like states in primary tumors, developmental reprogramming into a highly plastic fetal progenitor state, and then expression of non-intestinal lineage programs including squamous and neuroendocrine-like states.",{"name":70,"@type":61,"acceptedAnswer":71},"How is PROX1 involved in controlling lineage plasticity?",{"text":72,"@type":64},"PROX1 is induced with the fetal progenitor state and functions to repress non-intestinal lineage genes; downregulation of PROX1 licenses non-canonical reprogramming.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},337336,1790144344,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":97,"preview_urls":147},1099514068365,"https://ap-avatar.wpscdn.com/avatar/10000253d8d9f28188e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1794309523707217728","Article  \n\n| Progressive plasticity during colorectal cancer metastasis |  |  |\n| --- | --- | --- |\n| [https://doi.org/10.1038/s41586-024-08150-0](https://doi.org/10.1038/s41586-024-08150-0)\u003Cbr>Received: 10 July 2023 Accepted: 2 October 2024 Published online: 30 October 2024 Open access\u003Cbr> Check for updates | Andrew Moorman1,13, Elizabeth K. Benitez2,3,13, Francesco Cambuli2,10,13, Qingwen Jiang2, Ahmed Mahmoud2,4, Melissa Lumish2,5,11, Saskia Hartner2, Sasha Balkaran2, Jonathan Bermeo2, Simran Asawa2, Canan Firat6, AshaSaxena5, Fan Wu7, Anisha Luthra7, Cassandra Burdziak1, Yubin Xie1,8, Valeria Sgambati2, Kathleen Luckett2,3, Yanyun Li6,12, Zhifan Yi6, Ignas Masilionis1, Kevin Soares7, Emmanouil Pappou7, Rona Yaeger5, T. Peter Kingham7, William Jarnagin7, Philip B. Paty7, Martin R. Weiser7, Linas Mazutis1, Michael D’Angelica7, Jinru Shia6,\u003Cbr>Julio Garcia-Aguilar7, Tal Nawy1, Travis J. Hollmann6,12, Ronan Chaligné1,\u003Cbr>Francisco Sanchez-Vega7, Roshan Sharma1, Dana Pe’er1,9 ✉ & Karuna Ganesh2,5 ✉\u003Cbr>As cancers progress, they become increasingly aggressive—metastatic tumours are less responsive to first-line therapies than primary tumours, they acquire resistance to successive therapies and eventually cause death1,2. Mutations are largely conserved between primary and metastatic tumours from the same patients, suggesting that non-genetic phenotypic plasticity has a major role in cancer progression and therapy resistance3–5. However, we lack an understanding of metastatic cell states and the mechanisms by which they transition. Here, ina cohort of biospecimen trios from same-patient normal colon, primary and metastatic colorectal cancer, we show that, although primary tumours largely adopt LGR5+ intestinal stem-like states, metastases display progressive plasticity. Cancer cells lose intestinal cell identities andreprogram into a highly conserved fetal progenitor state before undergoing non-canonical differentiation into divergent squamousand neuroendocrine-like states, a process that is exacerbated in metastasis and by chemotherapy andisassociated with poor patient survival. Using matched patient-derived organoids, we demonstrate that metastatic cells exhibit greater cell-autonomous multilineage differentiation potential in response to microenvironment cues compared with their intestinal lineage-restricted primary tumour counterparts. We identify PROX1 asa repressor of non-intestinal lineage in the fetal progenitor state, and show that downregulation ofPROX1 licenses non-canonical reprogramming. |  |\n| As surgical resection of metastases is uncommon, cancer cell-state |  | hemicolectomy and metastasectomy, including both treatment-naive |\n| transitions during tumour progression inpatients remain largely unre- |  | patients and those who received pre-operative chemotherapy. Using |\n| solved. Colorectal cancer (CRC), for which the simultaneous resection |  | single-cell RNA-seq (scRNA-seq), multiplexed immunofluorescence |\n| of matched trios of primary tumour, normal colon and metastasis (frequently from liver) is a standard of care, offers a unique opportunity to |  | and epithelial organoid generation from matched trios, we found that CRC progression involves three distinct, ordered cell-state tran- |\n| study phenotypic transitions. While CRC largely initiates from LGR5+ |  | sitions: (1) from differentiated intestinal states in normal colonto an |\n| intestinal stem cells (ISCs)6,7, metastasis-initiating cells atthe invasion |  | LGR5+ ISC-like state enriched in primary tumour; (2) developmental |\n| front enter anLGR5low (refs.8,9), L1CAM+ (ref. 10) tumour regenerative |  | reprogramming to a highly plastic progenitor-like fetal state associ- |\n| state. However, the phenotypic states, trajectories and dependencies |  | ated with epithelial injury; and (3) expression of non-intestinal lineage |\n| of macrometastases emerging from L1CAM+ progenitors remain poorly |  | gene programs, including squamousand neuroendocrine, which are","cbCainiKcpfmV0zj","https://ap.wps.com/l/cbCainiKcpfmV0zj","pdf",84542164,41,"English","# Progressive plasticity and metastatic cell-state transitions\n## Ordered trajectories from primary to metastasis\n## Non-canonical differentiation and lineage reprogramming\n## Patient-derived organoid evidence\n## PROX1 as a lineage restriction repressor","[{\"question\":\"What does the study propose about metastatic progression in colorectal cancer?\",\"answer\":\"Metastatic tumors progress through an ordered, progressive plasticity program rather than relying mainly on genetic differences, enabling major phenotypic state transitions.\"},{\"question\":\"What distinct cell-state transitions are reported from primary tumors to metastases?\",\"answer\":\"The progression follows three ordered steps: enriched LGR5+ ISC-like states in primary tumors, developmental reprogramming into a highly plastic fetal progenitor state, and then expression of non-intestinal lineage programs including squamous and neuroendocrine-like states.\"},{\"question\":\"How is PROX1 involved in controlling lineage plasticity?\",\"answer\":\"PROX1 is induced with the fetal progenitor state and functions to repress non-intestinal lineage genes; downregulation of PROX1 licenses non-canonical reprogramming.\"}]","Progressive plasticity during colorectal cancer metastasis - Research findings | PDF",1790018639,103,[148,152,156,160,164],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e15b8574b1aed89d6c212ba694a1f887.webp",983,1305,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/09c045b412b9abf911ddcde8f0db9e7c.webp",982,1304,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5f12f4c351bd4cae567b210a43d2433b.webp",981,1303,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c0cfba42e79b70e1434a896a86bcaac5.webp",980,1301,{"page_no":97,"url":165,"width":166,"height":167},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cb6d60d027547d56066dad241d360639.webp",979,1300]